glauconex Uses, Dosage, Side Effects and more
glauconex is a beta blocker introduced in 1983 by Kakenyaku Kakko. It is currently in experimental status, and is being tested for the management of open angle glaucoma.
| Trade Name | glauconex |
| Generic | Befunolol |
| Befunolol Other Names | Befunolol, Befunololum |
| Weight | 0.25%, 0.5%, |
| Type | Solution/ Drops |
| Formula | C16H21NO4 |
| Weight | Average: 291.347 Monoisotopic: 291.14705816 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | Dr, Thilo Laboratories |
| Available Country | Saudi Arabia, |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Used in the management of open angle glaucoma. PMID: 12480285.
